About Albert David Ltd
Data last updated: 06 January 2026
Albert David Ltd is a public limited company based in Kolkata, West Bengal, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 16 November 1938, the company has been in operation for over 88 years.
Registered with ROC Kolkata under CIN U51109WB1938PLC009490. Listed on BSE: 524075 and NSE: ALBERTDAVD.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.71 Cr. It is led by directors including Monjori Mitra and Anand Vardhan Kothari.
Last AGM: 02 August 2025. Financial statements filed for year ended 31 March 2025. Office: 'D' Block 3Rd Floor Gillander House Netaji Subhas Road, Kolkata, West Bengal, India – 700001.
As per the financials filed for FY 2024, the company reported a revenue of ₹420.01 Cr, a growth of 18% compared to the previous year.
The company has a workforce of approximately 1,344 employees as per the latest available data.
The company is associated with 1 brand - Albert David India. As per MCA filings, the company has open charges of ₹57 Cr and satisfied charges of ₹43 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website albertdavidindia.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address'D' Block 3Rd Floor Gillander House Netaji Subhas Road, Kolkata, West Bengal, India – 700001
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Albert David Ltd
Albert David Ltd has one previous CIN (Corporate Identification Number): U51109WB1938PLC009490. The current CIN is L51109WB1938PLC009490, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51109WB1938PLC009490 | Current |
| U51109WB1938PLC009490 | Previous |
Associated Brands with Albert David Ltd
Albert David Ltd operates one associated brand: Albert David India. These brands represent Albert David Ltd's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations, infusions, and syringes are manufactured. | albertdavidindia.com |
Competitors & Alternatives of Albert David Ltd
Brands and companies operating in the same space as Albert David Ltd include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Albert David Ltd
Albert David Ltd is engaged in principal business activities including manufacturing and trade, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Albert David Ltd
Albert David Ltd is audited by L B Jha & Co. (ICAI peer reviewed, certificate valid till 2028-01-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| L B Jha & Co. (ICAI peer reviewed, certificate valid till 2028-01-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Albert David Ltd
Albert David Ltd is currently managed by 11 directors, with 26 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monjori Mitra | Director | 24 Aug 2020 | 5 Years 10 Months | Current |
|
Anand Vardhan Kothari
Also directs:
Bharat Fritz Werner Limited, Shubh Ananda Advisory Private Limited, Kothari Phytochemicals & Industries Ltd and 1 more
|
Director | 11 May 2022 | 4 Years 1 Months | Current |
| Shourya Sengupta | Director | 10 Aug 2023 | 2 Years 10 Months | Current |
|
Prabhawati Devi Kothari
Also directs:
Gillanders Arbuthnot & Co Ltd, Bharat Fritz Werner Limited, G Das & Co Pvt Ltd and 1 more
|
Director | 31 Mar 2014 | 12 Years 3 Months | Current |
|
Arun Kumar Kothari
Also directs:
Gillanders Arbuthnot & Co Ltd, Bharat Fritz Werner Limited, Arunudaya Consultancy Private Limited and 4 more
|
Whole-Time Director | 20 Jun 1988 | 38 Years 0 Months | Current |
|
Naresh Pachisia
Also directs:
Century Plyboards (India) Ltd., Skp Securities Ltd., Orbit Regency Maintenance Company Private Limited and 5 more
|
Director | 14 Nov 2024 | 1 Years 7 Months | Current |
Financials of Albert David Ltd FY 2026 filings available
Albert David Ltd reported revenue of ₹333.6 Cr (down 3.52% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹333.6 Cr | ₹345.77 Cr | ₹362.46 Cr | ₹341.56 Cr | ₹313.51 Cr | ₹247.45 Cr | ₹320.8 Cr |
| Other Income | ₹7.45 Cr | ₹29.58 Cr | ₹57.55 Cr | ₹15.4 Cr | ₹15.84 Cr | ₹17.18 Cr | ₹7.11 Cr |
| Total Income | ₹341.05 Cr | ₹375.35 Cr | ₹420.01 Cr | ₹356.96 Cr | ₹329.35 Cr | ₹264.63 Cr | ₹327.91 Cr |
| Cost of Materials Consumed | ₹59.89 Cr | ₹70.15 Cr | ₹63.92 Cr | ₹63.54 Cr | ₹51.46 Cr | ₹36.75 Cr | ₹56.1 Cr |
| Purchases of Stock-in-Trade | ₹49.01 Cr | ₹60.46 Cr | ₹64.25 Cr | ₹64.15 Cr | ₹61.1 Cr | ₹46.12 Cr | ₹52.32 Cr |
| Changes in Inventories | ₹4.96 Cr | -₹14.33 Cr | -₹1.77 Cr | -₹4.6 Cr | ₹2.38 Cr | ₹3.3 Cr | -₹3.03 Cr |
| Employee Benefit Expense | ₹102.48 Cr | ₹109.02 Cr | ₹88.43 Cr | ₹81.07 Cr | ₹85.38 Cr | ₹82.7 Cr | ₹90.34 Cr |
| Finance Costs | ₹2.63 Cr | ₹41.04 Lakh | ₹32.12 Lakh | ₹45.59 Lakh | ₹53.23 Lakh | ₹65.32 Lakh | ₹79.6 Lakh |
| Depreciation & Amortisation | ₹9.76 Cr | ₹6.97 Cr | ₹6.83 Cr | ₹8.55 Cr | ₹8.81 Cr | ₹8.23 Cr | ₹7.67 Cr |
| Other Expenses | ₹111.79 Cr | ₹117.43 Cr | ₹100.75 Cr | ₹93.06 Cr | ₹72.4 Cr | ₹59.43 Cr | ₹94.74 Cr |
| Total Expenses | ₹340.53 Cr | ₹350.12 Cr | ₹322.73 Cr | ₹306.23 Cr | ₹282.06 Cr | ₹237.19 Cr | ₹298.95 Cr |
| Profit Before Exceptional Items & Tax | ₹52.49 Lakh | ₹25.23 Cr | ₹97.29 Cr | ₹50.74 Cr | ₹47.3 Cr | ₹27.44 Cr | ₹28.95 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹52.49 Lakh | ₹25.23 Cr | ₹97.29 Cr | ₹50.74 Cr | ₹47.3 Cr | ₹27.44 Cr | ₹28.95 Cr |
| Total Tax Expense | ₹2.02 Cr | ₹8.03 Cr | ₹21.87 Cr | ₹14.56 Cr | ₹12.04 Cr | ₹5.3 Cr | ₹9.79 Cr |
| Net Profit | -₹1.49 Cr | ₹17.2 Cr | ₹75.42 Cr | ₹36.17 Cr | ₹35.26 Cr | ₹22.14 Cr | ₹19.17 Cr |
| Other Comprehensive Income | ₹3.4 Cr | -₹1.14 Cr | ₹1.12 Cr | ₹1.06 Cr | ₹3.26 Cr | -₹55.89 Lakh | ₹2.13 Cr |
| Total Comprehensive Income | ₹1.91 Cr | ₹16.07 Cr | ₹76.54 Cr | ₹37.24 Cr | ₹38.51 Cr | ₹21.58 Cr | ₹21.3 Cr |
| EBITDA (computed) | ₹12.92 Cr | ₹32.61 Cr | ₹104.43 Cr | ₹59.74 Cr | ₹56.64 Cr | ₹36.33 Cr | ₹37.43 Cr |
| Basic EPS | ₹-2.62 | ₹30.14 | ₹132.15 | ₹63.39 | ₹61.78 | ₹38.80 | ₹33.59 |
| Diluted EPS | ₹-2.62 | ₹30.14 | ₹132.15 | ₹63.39 | ₹61.78 | ₹38.80 | ₹33.59 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹519.13 Cr | ₹511.42 Cr | ₹497.99 Cr | ₹423.39 Cr |
| Non-current Assets | ₹144.73 Cr | ₹157.37 Cr | ₹126.36 Cr | ₹119.98 Cr |
| Current Assets | ₹374.4 Cr | ₹354.05 Cr | ₹371.63 Cr | ₹303.41 Cr |
| Property, Plant & Equipment | ₹99.07 Cr | ₹97.71 Cr | ₹81.6 Cr | ₹77.56 Cr |
| Inventories | ₹58.27 Cr | ₹63.9 Cr | ₹43.61 Cr | ₹50.68 Cr |
| Trade Receivables | ₹33.92 Cr | ₹27.37 Cr | ₹29.33 Cr | ₹30.33 Cr |
| Cash & Equivalents | ₹29.91 Lakh | ₹41.73 Lakh | ₹5.44 Cr | ₹1.45 Cr |
| Equity (Net Worth) | ₹391.54 Cr | ₹392.48 Cr | ₹382.98 Cr | ₹311.57 Cr |
| Equity Share Capital | ₹5.71 Cr | ₹5.71 Cr | ₹5.71 Cr | ₹5.71 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹62.28 Lakh |
| Borrowings (Current) | ₹28.48 Cr | ₹10.05 Cr | ₹2.1 Cr | ₹4.7 Cr |
| Total Debt (computed) | ₹28.48 Cr | ₹10.05 Cr | ₹2.1 Cr | ₹5.32 Cr |
| Current Liabilities | ₹115.43 Cr | ₹104.18 Cr | ₹99.05 Cr | ₹98.94 Cr |
| Total Liabilities | ₹127.6 Cr | ₹118.93 Cr | ₹115.01 Cr | ₹111.82 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹7.66 Cr | -₹28.44 Cr | ₹45.5 Cr | ₹10.52 Cr | ₹40.36 Cr |
| Investing Cash Flow | -₹4.4 Cr | ₹23.3 Cr | -₹33.25 Cr | -₹5 Cr | -₹39.7 Cr |
| Financing Cash Flow | ₹11.92 Cr | ₹11.03 Lakh | -₹8.27 Cr | -₹6.36 Cr | -₹4.88 Cr |
| Capital Expenditure | ₹0 | ₹14.86 Cr | ₹10.87 Cr | ₹5.24 Cr | ₹7.58 Cr |
| Free Cash Flow (computed) | -₹7.66 Cr | -₹43.29 Cr | ₹34.63 Cr | ₹5.28 Cr | ₹32.79 Cr |
| Dividends Paid | ₹2.86 Cr | ₹24.73 Lakh | ₹5.17 Cr | ₹5.15 Cr | ₹3.44 Cr |
| Net Change in Cash | -₹11.83 Lakh | -₹5.02 Cr | ₹3.99 Cr | -₹83.08 Lakh | -₹4.13 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹85.86 Cr | ₹89.93 Cr | ₹87.24 Cr | ₹70.57 Cr | ₹74.89 Cr | ₹83.08 Cr | ₹98.44 Cr | ₹89.36 Cr | ₹89.06 Cr | ₹88.28 Cr | ₹93.18 Cr | ₹91.95 Cr |
| Other Income | -₹24.84 Cr | ₹12.4 Cr | -₹2.14 Cr | ₹22.04 Cr | -₹5.11 Cr | -₹9.01 Cr | ₹20.64 Cr | ₹23.06 Cr | ₹10.44 Cr | ₹16.88 Cr | ₹12.1 Cr | ₹18.13 Cr |
| Total Income | ₹61.03 Cr | ₹102.33 Cr | ₹85.1 Cr | ₹92.6 Cr | ₹69.78 Cr | ₹74.08 Cr | ₹119.07 Cr | ₹112.42 Cr | ₹99.5 Cr | ₹105.16 Cr | ₹105.27 Cr | ₹110.08 Cr |
| Cost of Materials Consumed | ₹17.91 Cr | ₹16.75 Cr | ₹11.99 Cr | ₹13.25 Cr | ₹20.9 Cr | ₹17.43 Cr | ₹16.33 Cr | ₹15.5 Cr | ₹17.35 Cr | ₹15.81 Cr | ₹14.78 Cr | ₹15.45 Cr |
| Purchases of Stock-in-Trade | ₹14.06 Cr | ₹14.58 Cr | ₹10.45 Cr | ₹9.91 Cr | ₹18.55 Cr | ₹16.32 Cr | ₹12.67 Cr | ₹12.92 Cr | ₹19.53 Cr | ₹15.44 Cr | ₹13.87 Cr | ₹15.33 Cr |
| Changes in Inventories | -₹1.88 Cr | -₹3.5 Cr | ₹8.21 Cr | ₹2.12 Cr | -₹10.12 Cr | -₹7.41 Cr | ₹1.32 Cr | ₹1.88 Cr | -₹7.23 Cr | ₹1.55 Cr | ₹3 Cr | ₹90.54 Lakh |
| Employee Benefit Expense | ₹23.08 Cr | ₹23.9 Cr | ₹27.07 Cr | ₹28.43 Cr | ₹22.68 Cr | ₹28.61 Cr | ₹29.31 Cr | ₹28.37 Cr | ₹22.72 Cr | ₹23.09 Cr | ₹20.43 Cr | ₹22.2 Cr |
| Finance Costs | ₹42.91 Lakh | ₹89.77 Lakh | ₹75.07 Lakh | ₹55.48 Lakh | ₹13.15 Lakh | ₹12.76 Lakh | ₹5.81 Lakh | ₹9.32 Lakh | ₹6.8 Lakh | ₹11.85 Lakh | ₹5.75 Lakh | ₹7.72 Lakh |
| Depreciation & Amortisation | ₹2.72 Cr | ₹2.42 Cr | ₹2.23 Cr | ₹2.39 Cr | ₹1.82 Cr | ₹1.7 Cr | ₹1.67 Cr | ₹1.79 Cr | ₹1.83 Cr | ₹1.68 Cr | ₹1.46 Cr | ₹1.85 Cr |
| Other Expenses | ₹29.93 Cr | ₹27.37 Cr | ₹26.97 Cr | ₹27.51 Cr | ₹27.63 Cr | ₹27.47 Cr | ₹32.58 Cr | ₹29.81 Cr | ₹27.12 Cr | ₹24.04 Cr | ₹25.14 Cr | ₹25.07 Cr |
| Total Expenses | ₹86.26 Cr | ₹82.42 Cr | ₹87.68 Cr | ₹84.16 Cr | ₹81.59 Cr | ₹84.24 Cr | ₹93.94 Cr | ₹90.36 Cr | ₹81.39 Cr | ₹81.73 Cr | ₹78.73 Cr | ₹80.89 Cr |
| Profit Before Exceptional Items & Tax | -₹25.23 Cr | ₹19.9 Cr | -₹2.58 Cr | ₹8.44 Cr | -₹11.81 Cr | -₹10.16 Cr | ₹25.13 Cr | ₹22.06 Cr | ₹18.11 Cr | ₹23.44 Cr | ₹26.55 Cr | ₹29.19 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹25.23 Cr | ₹19.9 Cr | -₹2.58 Cr | ₹8.44 Cr | -₹11.81 Cr | -₹10.16 Cr | ₹25.13 Cr | ₹22.06 Cr | ₹18.11 Cr | ₹23.44 Cr | ₹26.55 Cr | ₹29.19 Cr |
| Total Tax Expense | -₹3.8 Cr | ₹4.6 Cr | ₹71.96 Lakh | ₹50.07 Lakh | -₹1.48 Cr | -₹77.29 Lakh | ₹7.06 Cr | ₹3.22 Cr | ₹5.2 Cr | ₹4.72 Cr | ₹6.25 Cr | ₹5.7 Cr |
| Net Profit | -₹21.43 Cr | ₹15.3 Cr | -₹3.3 Cr | ₹7.94 Cr | -₹10.33 Cr | -₹9.39 Cr | ₹18.07 Cr | ₹18.84 Cr | ₹12.91 Cr | ₹18.72 Cr | ₹20.3 Cr | ₹23.49 Cr |
| Other Comprehensive Income | ₹2.37 Cr | ₹1.4 Cr | -₹18.53 Lakh | -₹18.36 Lakh | -₹1.18 Cr | ₹14.17 Lakh | -₹30.21 Lakh | ₹20.31 Lakh | ₹1.15 Cr | -₹8.6 Lakh | ₹12.3 Lakh | -₹5.93 Lakh |
| Total Comprehensive Income | -₹19.07 Cr | ₹16.71 Cr | -₹3.49 Cr | ₹7.75 Cr | -₹11.51 Cr | -₹9.25 Cr | ₹17.77 Cr | ₹19.05 Cr | ₹14.06 Cr | ₹18.63 Cr | ₹20.42 Cr | ₹23.43 Cr |
| EBITDA (computed) | -₹22.08 Cr | ₹23.22 Cr | ₹39.68 Lakh | ₹11.38 Cr | -₹9.86 Cr | -₹8.34 Cr | ₹26.86 Cr | ₹23.94 Cr | ₹20.01 Cr | ₹25.24 Cr | ₹28.06 Cr | ₹31.12 Cr |
| Basic EPS | ₹-37.56 | ₹26.81 | ₹-5.79 | ₹13.91 | ₹-18.10 | ₹-16.45 | ₹31.67 | ₹33.02 | ₹22.63 | ₹32.80 | ₹35.57 | ₹41.16 |
| Diluted EPS | ₹-37.56 | ₹26.81 | ₹-5.79 | ₹13.91 | ₹-18.10 | ₹-16.45 | ₹31.67 | ₹33.02 | ₹22.63 | ₹32.80 | ₹35.57 | ₹41.16 |
Board & Governance of Albert David Ltd
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Albert David Ltd has 8 directors - 5 independent and 1 executive. The board is chaired by Arun Kumar Kothari.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Arun Kumar Kothari | Executive Director · Chairperson | 1988-06-20 | 3 |
| Prabhawati Devi Kothari | Non-Executive - Non Independent Director | 2014-03-31 | 2 |
| Anand Vardhan Kothari | Non-Executive - Non Independent Director | 2022-05-11 | 1 |
| Anurag Singhi | Non-Executive - Independent Director | 2024-04-01 | 1 |
| Monjori Mitra | Non-Executive - Independent Director | 2020-08-24 | 2 |
| Shourya Sengupta | Non-Executive - Independent Director | 2023-11-01 | 3 |
| Naresh Pachisia | Non-Executive - Independent Director | 2024-11-14 | 3 |
| Rajiv Anant Desai | Non-Executive - Independent Director | 2025-08-02 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Anurag Singhi (Chairperson), Arun Kumar Kothari, Naresh Pachisia, Rajiv Anant Desai |
| Nomination and remuneration committee | Anurag Singhi (Chairperson), Arun Kumar Kothari, Shourya Sengupta, Monjori Mitra |
| Stakeholders Relationship Committee | Monjori Mitra (Chairperson), Arun Kumar Kothari, Prabhawati Devi Kothari, Naresh Pachisia |
| Corporate Social Responsibility Committee | Arun Kumar Kothari (Chairperson), Prabhawati Devi Kothari, Shourya Sengupta, Rajiv Anant Desai |
Charges & Borrowings of Albert David Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2025 | Others | ₹20 Cr | Open |
| 18 May 2004 | State Bank of India | ₹18.5 Cr | Open |
| 17 Jun 1981 | State Bank of India | ₹18.5 Cr | Open |
| 31 Aug 2015 | State Bank of India | ₹35 Cr | Satisfied |
| 13 Jul 2009 | State Bank of India | ₹8 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Albert David Ltd
View historical data on people associated with Albert David Ltd, including employment history and EPFO contributions.
Employee Count & EPFO Data of Albert David Ltd
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Albert David Ltd
GSTIN & GST Filing Data of Albert David Ltd
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Albert David Ltd
Credit Ratings, Legal Cases & Regulatory Alerts of Albert David Ltd
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Albert David Ltd
MSME Payment Delays by Albert David Ltd
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Albert David Ltd
Subsidiaries & Group Companies of Albert David Ltd
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Albert David Ltd with ownership details.
MCA Filings & Documents of Albert David Ltd
MCA Filings & Documents of Albert David Ltd
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Albert David Ltd
Recent News on Albert David Ltd
Frequently Asked Questions about Albert David Ltd
Albert David Ltd is an active public limited company in the pharma sector based in Kolkata, West Bengal, India. It was incorporated on 16 November 1938 (88+ years old) and is registered under CIN L51109WB1938PLC009490. Listed on BSE: 524075 and NSE: ALBERTDAVD. The company has 1,344 employees.
Albert David Ltd reported revenue of ₹420.01 Cr for FY 2024 (up 18.00% YoY).
The current directors of Albert David Ltd are:
- Monjori Mitra
- Anand Vardhan Kothari
- Ranadeep Bhattacharya
- Shourya Sengupta
- Prabhawati Devi Kothari
- Arun Kumar Kothari
- Lalit Lohia
- Naresh Pachisia
- Umesh Manohar Kunte
- Anurag Singhi
- Rajiv Anant Desai
The primary industry of Albert David Ltd is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Albert David Ltd is listed on both BSE (code: 524075) and NSE (symbol: ALBERTDAVD).
Albert David Ltd can be reached at the registered office: D Block 3Rd Floor Gillander House Netaji Subhas Road, Kolkata, West Bengal, India – 700001, or through the website albertdavidindia.com.